Working… Menu

Oral Tazemetostat in Combination With Rituximab in R/R FL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04590820
Recruitment Status : Terminated (Study was transferred to Epizyme under NCT04762160 and new study number EZH-1401)
First Posted : October 19, 2020
Last Update Posted : March 3, 2021
Epizyme, Inc.
Information provided by (Responsible Party):
Swedish Medical Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 29, 2021
Actual Study Completion Date : January 29, 2021